NSG 1540 Pharmacotherapeutics Final
Practice Questions And Correct Answers
(Verified Answers) Plus Rationale 2027
Q&A| Instant Download Pdf.
1. Which phase of pharmacokinetics describes the movement of a
drug from the site of administration into systemic circulation?
A. Distribution
B. Metabolism
C. Absorption
D. Excretion
Rationale: Absorption is the process by which a drug moves from its
administration site into the bloodstream.
2. Which organ is primarily responsible for drug metabolism?
A. Kidney
B. Heart
C. Lungs
D. Liver
Rationale: The liver is the major site of drug metabolism, particularly
through hepatic enzyme systems such as the cytochrome P450
system.
3. Which pharmacokinetic process removes drugs from the body?
A. Absorption
B. Distribution
,C. Excretion
D. Binding
Rationale: Excretion eliminates drugs and metabolites, primarily
through the kidneys.
4. A medication with a high first-pass effect will generally have:
A. Increased bioavailability
B. Decreased oral bioavailability
C. Faster renal excretion
D. Increased protein binding
Rationale: Extensive metabolism during the first passage through the
liver can substantially reduce the amount of orally administered drug
reaching systemic circulation.
5. What does a drug's half-life indicate?
A. Time required for absorption
B. Time required for metabolism to begin
C. Time required for the drug concentration to decrease by 50%
D. Time required for the drug to reach peak effect
Rationale: Half-life is the time required for the plasma concentration
of a drug to decrease by one-half.
6. Which route generally provides 100% bioavailability?
A. Oral
B. Subcutaneous
C. Intramuscular
D. Intravenous
,Rationale: IV administration places the medication directly into
systemic circulation, resulting in complete bioavailability.
7. A medication binds to plasma albumin. What is the primary
significance of this binding?
A. It immediately increases renal excretion
B. It creates a reservoir of drug that is not immediately
pharmacologically active
C. It guarantees therapeutic effectiveness
D. It prevents metabolism
Rationale: Protein-bound drug is generally less available for receptor
interaction and can serve as a reservoir that releases drug as free
concentrations decrease.
8. Which patient is at greatest risk for accumulation of a renally
excreted medication?
A. A patient with normal renal function
B. A young adult with adequate hydration
C. A patient with significant renal impairment
D. A patient taking medication with food
Rationale: Reduced renal clearance can prolong drug elimination and
cause accumulation and toxicity.
9. Pharmacodynamics primarily concerns:
A. How the body absorbs medications
B. How medications are eliminated
C. How drugs affect the body
D. How drugs are stored
, Rationale: Pharmacodynamics describes drug actions and effects on
physiological processes.
10. An agonist is a medication that:
A. Blocks all receptors
B. Activates a receptor to produce a response
C. Prevents absorption
D. Accelerates excretion
Rationale: Agonists bind to receptors and activate them to produce a
physiological response.
11. An antagonist primarily:
A. Activates receptors
B. Increases absorption
C. Blocks or reduces receptor activation
D. Increases drug metabolism
Rationale: Antagonists bind to receptors without producing the
intended activating response and can prevent agonists from acting.
12. Which term describes the concentration of a drug required to
produce a specified effect?
A. Half-life
B. Clearance
C. Potency
D. Bioavailability
Rationale: Potency refers to the amount or concentration of drug
needed to produce a particular effect.
Practice Questions And Correct Answers
(Verified Answers) Plus Rationale 2027
Q&A| Instant Download Pdf.
1. Which phase of pharmacokinetics describes the movement of a
drug from the site of administration into systemic circulation?
A. Distribution
B. Metabolism
C. Absorption
D. Excretion
Rationale: Absorption is the process by which a drug moves from its
administration site into the bloodstream.
2. Which organ is primarily responsible for drug metabolism?
A. Kidney
B. Heart
C. Lungs
D. Liver
Rationale: The liver is the major site of drug metabolism, particularly
through hepatic enzyme systems such as the cytochrome P450
system.
3. Which pharmacokinetic process removes drugs from the body?
A. Absorption
B. Distribution
,C. Excretion
D. Binding
Rationale: Excretion eliminates drugs and metabolites, primarily
through the kidneys.
4. A medication with a high first-pass effect will generally have:
A. Increased bioavailability
B. Decreased oral bioavailability
C. Faster renal excretion
D. Increased protein binding
Rationale: Extensive metabolism during the first passage through the
liver can substantially reduce the amount of orally administered drug
reaching systemic circulation.
5. What does a drug's half-life indicate?
A. Time required for absorption
B. Time required for metabolism to begin
C. Time required for the drug concentration to decrease by 50%
D. Time required for the drug to reach peak effect
Rationale: Half-life is the time required for the plasma concentration
of a drug to decrease by one-half.
6. Which route generally provides 100% bioavailability?
A. Oral
B. Subcutaneous
C. Intramuscular
D. Intravenous
,Rationale: IV administration places the medication directly into
systemic circulation, resulting in complete bioavailability.
7. A medication binds to plasma albumin. What is the primary
significance of this binding?
A. It immediately increases renal excretion
B. It creates a reservoir of drug that is not immediately
pharmacologically active
C. It guarantees therapeutic effectiveness
D. It prevents metabolism
Rationale: Protein-bound drug is generally less available for receptor
interaction and can serve as a reservoir that releases drug as free
concentrations decrease.
8. Which patient is at greatest risk for accumulation of a renally
excreted medication?
A. A patient with normal renal function
B. A young adult with adequate hydration
C. A patient with significant renal impairment
D. A patient taking medication with food
Rationale: Reduced renal clearance can prolong drug elimination and
cause accumulation and toxicity.
9. Pharmacodynamics primarily concerns:
A. How the body absorbs medications
B. How medications are eliminated
C. How drugs affect the body
D. How drugs are stored
, Rationale: Pharmacodynamics describes drug actions and effects on
physiological processes.
10. An agonist is a medication that:
A. Blocks all receptors
B. Activates a receptor to produce a response
C. Prevents absorption
D. Accelerates excretion
Rationale: Agonists bind to receptors and activate them to produce a
physiological response.
11. An antagonist primarily:
A. Activates receptors
B. Increases absorption
C. Blocks or reduces receptor activation
D. Increases drug metabolism
Rationale: Antagonists bind to receptors without producing the
intended activating response and can prevent agonists from acting.
12. Which term describes the concentration of a drug required to
produce a specified effect?
A. Half-life
B. Clearance
C. Potency
D. Bioavailability
Rationale: Potency refers to the amount or concentration of drug
needed to produce a particular effect.
